Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Pneumonia in old age; active immunization against pneumonia with pneumonococcus polysaccharide; results of a six year study.

KAUFMAN P.

Arch Intern Med (Chic). 1947 May;79(5):518-31. No abstract available.

PMID:
20240871
4.

Persistence of antibodies in human subjects injected with pneumococcal polysaccharides.

HEIDELBERGER M, DILAPI MM, SIEGEL M, WALTER AW.

J Immunol. 1950 Nov;65(5):535-41. No abstract available.

PMID:
14794919
5.

Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 1999.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2001 Jun 29;50(25):532-7.

6.

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network.

JAMA. 2001 Apr 4;285(13):1729-35.

PMID:
11277827
8.

Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, Siber G, Mäkelä PH; Finnish Otitis Media Study Group.

N Engl J Med. 2001 Feb 8;344(6):403-9.

9.

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.

Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, Lefkowitz L, Cieslak PR, Cetron M, Zell ER, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network.

N Engl J Med. 2000 Dec 28;343(26):1917-24.

10.

Changing Epidemiology of Bacterial Meningitis in the United States.

Short WR, Tunkel AR.

Curr Infect Dis Rep. 2000 Aug;2(4):327-331.

PMID:
11095873
11.

A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women.

Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW.

Arch Intern Med. 2000 Nov 13;160(20):3082-8.

PMID:
11074737
12.

Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.

Briles DE, Hollingshead SK, King J, Swift A, Braun PA, Park MK, Ferguson LM, Nahm MH, Nabors GS.

J Infect Dis. 2000 Dec;182(6):1694-701. Epub 2000 Nov 8.

PMID:
11069242
13.

Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.

Heath PT, Booy R, Azzopardi HJ, Slack MP, Bowen-Morris J, Griffiths H, Ramsay ME, Deeks JJ, Moxon ER.

JAMA. 2000 Nov 8;284(18):2334-40.

PMID:
11066183
14.

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials.

Moore RA, Wiffen PJ, Lipsky BA.

BMC Fam Pract. 2000;1:1. Epub 2000 Oct 4.

15.

Influenza, pneumococcal, and tetanus toxioid vaccination of adults--United States, 1993-7.

Singleton JA, Greby SM, Wooten KG, Walker FJ, Strikas R.

MMWR CDC Surveill Summ. 2000 Sep 22;49(9):39-62.

16.

Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries.

Ament A, Baltussen R, Duru G, Rigaud-Bully C, de Graeve D, Ortqvist A, Jönsson B, Verhaegen J, Gaillat J, Christie P, Cifre AS, Vivas D, Loiseau C, Fedson DS.

Clin Infect Dis. 2000 Aug;31(2):444-50. Epub 2000 Sep 5.

PMID:
10987703
17.

Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries.

Kalin M, Ortqvist A, Almela M, Aufwerber E, Dwyer R, Henriques B, Jorup C, Julander I, Marrie TJ, Mufson MA, Riquelme R, Thalme A, Torres A, Woodhead MA.

J Infect Dis. 2000 Sep;182(3):840-7. Epub 2000 Aug 17.

PMID:
10950779
18.

Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study.

Musher DM, Alexandraki I, Graviss EA, Yanbeiy N, Eid A, Inderias LA, Phan HM, Solomon E.

Medicine (Baltimore). 2000 Jul;79(4):210-21.

20.

Immune function and vaccine responses in healthy advanced elderly patients.

Carson PJ, Nichol KL, O'Brien J, Hilo P, Janoff EN.

Arch Intern Med. 2000 Jul 10;160(13):2017-24.

PMID:
10888975

Supplemental Content

Support Center